Some plans cover the medication for patients with BMI 30 or BMI 27 with weight-related comorbidities, but prior authorization requirements, step therapy protocols, and high copayments create significant barriers
(cymbiotika.com) It is also important to remember that results vary
Sin embargo, no se sabe si la deficiencia de colina puede aumentar la susceptibilidad al cncer en humanos (2)
Run a big, long heart-outcomes trial, show you do no harm, get to market
Doubling wont make up for a missed dose and only increases the risk of side effects like prolonged vomiting or dangerously low blood pressure
As a result, they offer a less invasive option for B12 administration compared to traditional SubQ needles